Henan Xihe Chemical Technology Co., Ltd. is a foreign-funded company registered in June 2020, mainly producing pesticides and pharmaceutical intermediates, anti-tumor drugs and intermediates, progesterone and intermediate products, the project started construction in September 2020, divided into 3 phases of construction, it is planned to cover an area of 246 mu, the total investment is expected to be 670 million yuan (the first and second phases are expected to invest 120 million yuan, the third phase is expected to invest 550 million yuan), the current first and second phase of the project has acquired 46 acres of land, the first phase of pesticides and pharmaceutical intermediates, The desulfurizer workshop equipment has been completed and trial production will begin in July 2021; The workshop of the second phase of pharmaceutical and pharmaceutical intermediates project has completed construction and equipment installation, and is currently entering the equipment commissioning stage, which is expected to be completed and put into use in December 2022; The third phase of the anti-tumor drug production project is undergoing land acquisition work, and construction is expected to start in October 2023.

河南羲和化工科技有限公司是于2020年6月份注册成立的外资公司，主要生产农药及医药中间体、抗肿瘤药物及中间体、孕激素及中间体产品，项目于2020年9月份开工建设，分为3期投建，拟占地246亩，预计总投资6.7亿元（一二期预计投资1.2亿元，三期预计投资5.5亿元),目前一二期项目已征地46亩，一期农药及医药中间体、脱硫剂车间设备已建设完成并于2021年7月份开始试生产；二期医药及医药中间体项目车间已完成建设及设备安装目前进入设备调试阶段，预计2022年12月份建成投入使用；三期抗肿瘤药物生产项目正在进行土地征收工作，预计2023年10月份开工建设。

Intermediates, 3-Methyl-2-nitrobenzoic acid, 3-Methyl-4-nitrobenzoic acid, Liquid sodium nitrate

中间体，3-甲基-2-硝基苯甲酸，3-甲基-4-硝基苯甲酸，液体硝酸钠